83 related articles for article (PubMed ID: 2169344)
21. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
22. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
23. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
Lee CH; Yun HJ; Kang HS; Kim HD
IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
[TBL] [Abstract][Full Text] [Related]
24. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
Constantinou A; Henning-Chubb C; Huberman E
Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
[TBL] [Abstract][Full Text] [Related]
25. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
Shelly C; Petruzzelli L; Herrera R
Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
[TBL] [Abstract][Full Text] [Related]
26. Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.
Fukuda M
Cancer Res; 1981 Nov; 41(11 Pt 1):4621-8. PubMed ID: 7306980
[TBL] [Abstract][Full Text] [Related]
27. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(4B):3229-35. PubMed ID: 10652616
[TBL] [Abstract][Full Text] [Related]
28. Differential phosphorylation events associated with phorbol ester effects on acceleration versus inhibition of cell growth.
Feuerstein N; Sahai A; Anderson WB; Salomon DS; Cooper HL
Cancer Res; 1984 Nov; 44(11):5227-33. PubMed ID: 6593117
[TBL] [Abstract][Full Text] [Related]
29. Alteration in glycosphingolipid pattern during phorbol-12-myristate-13-acetate-induced cell differentiation in human T-lymphoid leukemia cells.
Kiguchi K; Henning-Chubb C; Huberman E
Cancer Res; 1986 Jun; 46(6):3027-33. PubMed ID: 3486042
[TBL] [Abstract][Full Text] [Related]
30. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
31. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
32. [Retinoic acid intensifies the suppression of the proliferation of K562 cells by phorbol ester].
Chistokhina AV; Medvedev AV
Tsitologiia; 1993; 35(8):52-8. PubMed ID: 8266575
[TBL] [Abstract][Full Text] [Related]
33. Changes in the patterns of protein phosphorylation associated with granulocytic and monocytic-induced differentiation of HL-60 cells.
Faille A; Poirier O; Turmel P; Chomienne C; Charron DJ; Abita JP
Anticancer Res; 1986; 6(5):1053-63. PubMed ID: 3467646
[TBL] [Abstract][Full Text] [Related]
34. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.
Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM
J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057
[TBL] [Abstract][Full Text] [Related]
36. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
[TBL] [Abstract][Full Text] [Related]
37. Decrease in the phosphotyrosine phosphatase activity in the plasma membrane of human neutrophils on stimulation by phorbol 12-myristate 13-acetate.
Kansha M; Takeshige K; Minakami S
Biochim Biophys Acta; 1993 Nov; 1179(2):189-96. PubMed ID: 8218360
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of hepatic protein tyrosine phosphatases.
Gruppuso PA; Boylan JM
Second Messengers Phosphoproteins; 1992-1993; 14(3):99-108. PubMed ID: 1345343
[TBL] [Abstract][Full Text] [Related]
39. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
[TBL] [Abstract][Full Text] [Related]
40. TSH-induced differentiated functions correlate with enhancement of phosphotyrosine phosphatase activity in thyroid cells. Effect of phorbol 12-myristate 13-acetate.
Petitfrère E; Huet E; Sartelet H; Martiny L; Legue O; Haye B
J Endocrinol; 2001 Jun; 169(3):603-11. PubMed ID: 11375131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
